These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745 [TBL] [Abstract][Full Text] [Related]
10. TREM2 Function in Alzheimer's Disease and Neurodegeneration. Ulrich JD; Holtzman DM ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the Role of TREM2 in Alzheimer's Disease. Ulrich JD; Ulland TK; Colonna M; Holtzman DM Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958 [TBL] [Abstract][Full Text] [Related]
12. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic? Lue LF; Schmitz C; Walker DG Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879 [TBL] [Abstract][Full Text] [Related]
13. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore. Gussago C; Casati M; Ferri E; Arosio B J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915 [TBL] [Abstract][Full Text] [Related]
14. Differential Phagocytic Properties of CD45 Rangaraju S; Raza SA; Li NX; Betarbet R; Dammer EB; Duong D; Lah JJ; Seyfried NT; Levey AI Front Immunol; 2018; 9():405. PubMed ID: 29552013 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and mechanism of cGAMP to suppress Alzheimer's disease by elevating TREM2. Xu Q; Xu W; Cheng H; Yuan H; Tan X Brain Behav Immun; 2019 Oct; 81():495-508. PubMed ID: 31283973 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs. Scoyni F; Giudice L; Väänänen MA; Downes N; Korhonen P; Choo XY; Välimäki NN; Mäkinen P; Korvenlaita N; Rozemuller AJ; de Vries HE; Polo J; Turunen TA; Ylä-Herttuala S; Hansen TB; Grubman A; Kaikkonen MU; Malm T Alzheimers Dement; 2024 Feb; 20(2):954-974. PubMed ID: 37828821 [TBL] [Abstract][Full Text] [Related]
17. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease. Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227 [TBL] [Abstract][Full Text] [Related]
18. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. Walker DG; Lue LF J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156 [TBL] [Abstract][Full Text] [Related]
19. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease. Hashemiaghdam A; Mroczek M J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774 [TBL] [Abstract][Full Text] [Related]
20. Vps35-dependent recycling of Trem2 regulates microglial function. Yin J; Liu X; He Q; Zhou L; Yuan Z; Zhao S Traffic; 2016 Dec; 17(12):1286-1296. PubMed ID: 27717139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]